In our first series, we set the stage with a deep look at the government and commercial payer landscape, covering coverage, reimbursement, and pricing, and how these factors can shape commercialization strategy in real time. While many business considerations around commercialization are well understood, this discussion shines a light on the legal and policy dimensions—critical factors that are often less familiar to biotechs at the earlier stages of drug development.
What is Demy-Colton Talks Biotech?
Where Visionary Leaders Share What’s Next in Biotech